文献速递类风湿关节炎

类风湿关节炎患者对血液检查的看法:ArthritisPower登记库中的一项横断面调查

Patient Perceptions of Rheumatoid Arthritis Blood Work: A Cross-Sectional Survey in the ArthritisPower Registry.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2023-08-31

该横断面调查纳入ArthritisPower登记库中类风湿关节炎患者,了解其对类风湿关节炎相关实验室检查的认知及对预测治疗反应血液检查的潜在效用。多数患者认为医生开具实验室检查用于检查活动性炎症(85.9%)或评估药物副作用(81.2%),89.2%表示对未来治疗需更换时能预测新药是否有效的血液检查非常/极其感兴趣。患者认为高准确性检测结果比低自付费用或短等待时间更重要。

要点

  • 多数患者认为实验室检查用于检查活动性炎症(85.9%)或评估药物副作用(81.2%)。
  • 91.4%患者担心当前药物最终会失效,81.7%担心尝试可能无效的新药会浪费时间。
  • 89.2%患者对能预测新药是否有效的血液检查非常/极其感兴趣,高准确性比低费用或短等待更重要。

核心结论

  • 患者认为类风湿关节炎相关血液检查对监测炎症和药物副作用重要,担心治疗有效性并愿意接受检测以准确预测治疗反应。

研究设计与样本

  • ArthritisPower登记库中类风湿关节炎成员的横断面调查,包含基于选择的联合分析练习以确定患者对生物标志物检测不同属性的重视程度。

主要发现

  • 多数患者认为医生开具实验室检查用于检查活动性炎症(85.9%)或评估药物副作用(81.2%)。
  • 用于监测类风湿关节炎最常开具的血液检查为全血细胞计数、肝功能检查以及测量C反应蛋白(CRP)和红细胞沉降率的检查。
  • 患者认为CRP对理解疾病活动度最有帮助。
  • 多数患者担心当前类风湿关节炎药物最终会停止工作(91.4%),并担心尝试可能对其无效的新药会浪费时间(81.7%)。
  • 对于未来需要更换类风湿关节炎治疗的患者,多数(89.2%)报告对能帮助预测新药是否有效的血液检查非常/极其感兴趣。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine how patients with rheumatoid arthritis (RA) perceive RA-related laboratory testing and the potential utility of a blood test to predict treatment response to a new RA medication. METHODS: ArthritisPower members with RA were invited to participate in a cross-sectional survey on reasons for laboratory testing plus a choice-based conjoint analysis exercise to determine how patients value different attributes of a biomarker-based test to predict treatment response. RESULTS: Most patients perceived that their doctors ordered laboratory tests to check for active inflammation (85.9%) or assess medication side effects (81.2%). The most commonly ordered blood tests used to monitor RA were complete blood counts, liver function tests, and those measuring C-reactive protein (CRP) and erythrocyte sedimentation rate. Patients felt CRP was most helpful in understanding their disease activity. Most worried their current RA medication would eventually stop working (91.4%) and they would waste time trying a new RA medication that may not work for them (81.7%). For patients who would require a future change in RA treatment, a majority (89.2%) reported that they would be very/extremely interested in a blood test that could help predict whether such new medication would be effective. Highly accurate test results (improving the chance RA medication will work from 50% to 85-95%) were more important to patients than low out-of-pocket cost (<$20) or minimal wait time (<7 days). CONCLUSIONS: Patients consider RA-related blood work important for monitoring of inflammation and medication side effects. They worry about treatment effectiveness and would undergo testing to accurately predict treatment response.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Nowell WB, Venkatachalam S, Gavigan K, et al. Patient Perceptions of Rheumatoid Arthritis Blood Work: A Cross-Sectional Survey in the ArthritisPower Registry. Arthritis Care Res (Hoboken). 2023. PMID: 37386276. doi:10.1002/acr.25187

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。